vs
Side-by-side financial comparison of Sensus Healthcare, Inc. (SRTS) and SWK Holdings Corp (SWKH). Click either name above to swap in a different company.
SWK Holdings Corp is the larger business by last-quarter revenue ($8.7M vs $4.9M, roughly 1.8× Sensus Healthcare, Inc.). On growth, SWK Holdings Corp posted the faster year-over-year revenue change (-29.7% vs -62.2%). SWK Holdings Corp produced more free cash flow last quarter ($26.8M vs $-2.4M). Over the past eight quarters, SWK Holdings Corp's revenue compounded faster (-12.5% CAGR vs -31.9%).
Sensus Healthcare, Inc. is a medical technology company that designs, manufactures and commercializes innovative non-invasive superficial radiation therapy systems. Its products are primarily used for treating non-melanoma skin cancers, keloids, and select cosmetic dermatology conditions, serving healthcare providers and clinical facilities worldwide.
SWK Holdings Corp is a specialty finance firm focused on the healthcare and life sciences sectors. It provides tailored financing solutions including royalty monetization, structured debt, and asset-backed lending to biotech, pharmaceutical, medical device and diagnostic companies, with its core market centered in North America.
SRTS vs SWKH — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $4.9M | $8.7M |
| Net Profit | $-3.2M | $-19.4M |
| Gross Margin | 38.4% | — |
| Operating Margin | -63.8% | 9.9% |
| Net Margin | -64.1% | — |
| Revenue YoY | -62.2% | -29.7% |
| Net Profit YoY | -304.9% | -430.2% |
| EPS (diluted) | $-0.19 | $-1.59 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $4.9M | $8.7M | ||
| Q3 25 | $6.9M | $10.9M | ||
| Q2 25 | $7.3M | $10.1M | ||
| Q1 25 | $8.3M | $11.8M | ||
| Q4 24 | $13.1M | $12.4M | ||
| Q3 24 | $8.8M | $10.4M | ||
| Q2 24 | $9.2M | $10.8M | ||
| Q1 24 | $10.7M | $11.4M |
| Q4 25 | $-3.2M | $-19.4M | ||
| Q3 25 | $-943.0K | $8.8M | ||
| Q2 25 | $-1.0M | $3.5M | ||
| Q1 25 | $-2.6M | $4.5M | ||
| Q4 24 | $1.5M | $5.9M | ||
| Q3 24 | $1.2M | $3.5M | ||
| Q2 24 | $1.6M | $3.7M | ||
| Q1 24 | $2.3M | $468.0K |
| Q4 25 | 38.4% | — | ||
| Q3 25 | 39.4% | — | ||
| Q2 25 | 39.7% | — | ||
| Q1 25 | 52.2% | — | ||
| Q4 24 | 54.4% | — | ||
| Q3 24 | 59.3% | — | ||
| Q2 24 | 58.7% | — | ||
| Q1 24 | 62.5% | — |
| Q4 25 | -63.8% | 9.9% | ||
| Q3 25 | -37.3% | 61.3% | ||
| Q2 25 | -26.6% | 46.1% | ||
| Q1 25 | -31.7% | 68.6% | ||
| Q4 24 | 13.2% | 44.7% | ||
| Q3 24 | 16.9% | 39.2% | ||
| Q2 24 | 21.5% | 8.3% | ||
| Q1 24 | 27.1% | 9.5% |
| Q4 25 | -64.1% | — | ||
| Q3 25 | -13.7% | 80.7% | ||
| Q2 25 | -14.2% | 35.2% | ||
| Q1 25 | -30.8% | 38.4% | ||
| Q4 24 | 11.8% | 47.5% | ||
| Q3 24 | 13.7% | 33.3% | ||
| Q2 24 | 17.4% | 33.9% | ||
| Q1 24 | 21.3% | 4.1% |
| Q4 25 | $-0.19 | $-1.59 | ||
| Q3 25 | $-0.06 | $0.72 | ||
| Q2 25 | $-0.06 | $0.29 | ||
| Q1 25 | $-0.16 | $0.37 | ||
| Q4 24 | $0.10 | $0.47 | ||
| Q3 24 | $0.07 | $0.28 | ||
| Q2 24 | $0.10 | $0.30 | ||
| Q1 24 | $0.14 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $22.1M | $42.8M |
| Total DebtLower is stronger | — | $33.0M |
| Stockholders' EquityBook value | $48.1M | $235.1M |
| Total Assets | $53.0M | $272.4M |
| Debt / EquityLower = less leverage | — | 0.14× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $22.1M | $42.8M | ||
| Q3 25 | $24.5M | $10.2M | ||
| Q2 25 | $22.2M | $8.0M | ||
| Q1 25 | $19.1M | $29.8M | ||
| Q4 24 | $22.1M | $5.9M | ||
| Q3 24 | $22.6M | $17.2M | ||
| Q2 24 | $19.0M | $5.5M | ||
| Q1 24 | $14.7M | $5.5M |
| Q4 25 | — | $33.0M | ||
| Q3 25 | — | $33.0M | ||
| Q2 25 | — | $33.0M | ||
| Q1 25 | — | $33.0M | ||
| Q4 24 | — | $33.0M | ||
| Q3 24 | — | $33.0M | ||
| Q2 24 | — | $33.0M | ||
| Q1 24 | — | $33.0M |
| Q4 25 | $48.1M | $235.1M | ||
| Q3 25 | $51.2M | $254.2M | ||
| Q2 25 | $52.1M | $246.5M | ||
| Q1 25 | $53.0M | $292.7M | ||
| Q4 24 | $55.8M | $288.7M | ||
| Q3 24 | $54.1M | $283.4M | ||
| Q2 24 | $52.9M | $282.8M | ||
| Q1 24 | $51.2M | $279.9M |
| Q4 25 | $53.0M | $272.4M | ||
| Q3 25 | $58.3M | $289.4M | ||
| Q2 25 | $58.9M | $285.7M | ||
| Q1 25 | $60.2M | $331.3M | ||
| Q4 24 | $62.2M | $332.2M | ||
| Q3 24 | $59.9M | $321.3M | ||
| Q2 24 | $58.2M | $321.0M | ||
| Q1 24 | $57.3M | $322.0M |
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.13× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | 0.11× | ||
| Q3 24 | — | 0.12× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.12× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.2M | $27.3M |
| Free Cash FlowOCF − Capex | $-2.4M | $26.8M |
| FCF MarginFCF / Revenue | -47.9% | 308.1% |
| Capex IntensityCapex / Revenue | 3.2% | 5.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $332.0K | $43.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.2M | $27.3M | ||
| Q3 25 | $2.3M | $906.0K | ||
| Q2 25 | $3.1M | $7.8M | ||
| Q1 25 | $-2.7M | $8.3M | ||
| Q4 24 | $-827.0K | $23.0M | ||
| Q3 24 | $4.0M | $6.3M | ||
| Q2 24 | $4.2M | $5.4M | ||
| Q1 24 | $-8.2M | $4.4M |
| Q4 25 | $-2.4M | $26.8M | ||
| Q3 25 | $2.3M | $557.0K | ||
| Q2 25 | $3.1M | $7.7M | ||
| Q1 25 | $-2.7M | $8.2M | ||
| Q4 24 | $-1.1M | $22.9M | ||
| Q3 24 | $3.6M | $6.3M | ||
| Q2 24 | $4.2M | $5.4M | ||
| Q1 24 | $-8.4M | — |
| Q4 25 | -47.9% | 308.1% | ||
| Q3 25 | 33.3% | 5.1% | ||
| Q2 25 | 42.2% | 77.0% | ||
| Q1 25 | -32.2% | 69.1% | ||
| Q4 24 | -8.6% | 185.3% | ||
| Q3 24 | 40.9% | 60.4% | ||
| Q2 24 | 45.8% | 49.7% | ||
| Q1 24 | -79.0% | — |
| Q4 25 | 3.2% | 5.9% | ||
| Q3 25 | 0.1% | 3.2% | ||
| Q2 25 | 0.4% | 0.6% | ||
| Q1 25 | 0.1% | 0.8% | ||
| Q4 24 | 2.3% | 1.1% | ||
| Q3 24 | 3.8% | 0.3% | ||
| Q2 24 | 0.0% | 0.2% | ||
| Q1 24 | 2.2% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.10× | ||
| Q2 25 | — | 2.21× | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | -0.53× | 3.93× | ||
| Q3 24 | 3.25× | 1.82× | ||
| Q2 24 | 2.62× | 1.47× | ||
| Q1 24 | -3.60× | 9.47× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SRTS
| Products | $2.8M | 57% |
| Other | $2.1M | 43% |
SWKH
| Finance Receivables Segment | $8.4M | 96% |
| Other | $329.0K | 4% |
